Please assess the completion status of the following clinical trial:

Trial Title: The Renin-Angiotensin System in Essential Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Essential Hypertension~* SBP 140-159 mmHg~* DBP 90-99 mmHg~Exclusion Criteria:~* Intolerance of or allergy to ACE Inhibitors or ARBS~* Pregnant or Breastfeeding~* Pre-menopausal women~* Uncontrolled cardiac or renal failure~* Diabetes mellitus

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).